DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /PyrrolesPyrroles
  6. /OfirnoflastOfirnoflast
Chemical structure of CAS 2731294-23-6

Ofirnoflast

In Stock•Starting at $1096 for 100 mg•Purity ≥ 98%
CAS No.2731294-23-6
MDL No.N/A
MFC23H19F4N7O2
MW501.40
InChI KeyMJUUWYZZPRAKCW-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
100 mg98%$1096In Stock
250 mg98%$1564In Stock
1 g98%$3121In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2731294-23-6
Product NameOfirnoflast
Heavy Atom Count36Rotatable Bond Count5
Atom Stereo Count0Bond Stereo Count0
HBA7HBD3
TPSA123.890 ŲCharge0
Exact Mass501.15364Complexity1502.14
pKa7.130XLogP5.380

Related Articles

Studies related to this compound and its mechanism of action

Ofirnoflast: a first-in-class NEK7-targeted inhibitor of the NLRP3 inflammasome.

Journal of drug targeting • Vol. 34, Issue 1 • 2026
PMID: 40754685DOI: 10.1080/1061186X.2025.2542856

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact